Please assess the completion status of the following clinical trial:

Trial Title: A Study for the Treatment of Diabetic Peripheral Neuropathic Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with pain due to bilateral peripheral neuropathy induced by type 1 or 2 diabetes mellitus. The pain must have been present for at least 6 months and be evaluable in feet, legs, or hands.~* Participants with hemoglobin A1c (HbA1c) less than or equal to 9.0 percent at Visit 1.~* Participants in whom HbA1c had been measured 42-70 days before Visit 1 and subsequent HbA1c levels have been within +/- 1.0 percent of the level at Visit 1.~* Participants with a mean of the 24-hour average pain severity scores (round off to a whole number) of 4 or higher, as calculated from the patient diary for 7 days immediately before Visit 2~Exclusion Criteria:~* Participants who have undergone renal transplant or who are currently on renal dialysis.~* Participants who have a history requiring pharmacotherapy within the past year or current history of psychiatric disease, such as mania, bipolar disorder, depression, anxiety disorder, or eating disorder.~* Participants with hypertension with poor control of blood pressure (systolic blood pressure greater than or equal to 180 millimeters of mercury (mmHg) or diastolic blood pressure greater than or equal to 110 mmHg~* Participants with alanine transaminase (ALT) or aspartate transaminase (AST) greater than or equal to 100 Units per Liter (U/L) at Visit 1.~* Participants unable to discontinue prohibited concomitant drugs or concomitant therapies after Visit 1.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- Duloxetine 60 (Type: EXPERIMENTAL): duloxetine 60 milligram (mg) taken orally every day
- Duloxetine 40 (Type: EXPERIMENTAL): Duloxetine 40 mg taken orally every day
- Placebo (Type: PLACEBO_COMPARATOR): placebo comparator taken orally every day

Based on this trial design, predict the completion outcome and termination type (if applicable).